# Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension

> **NCT06258785** · PHASE3 · COMPLETED · sponsor: **Endeavor Health** · enrollment: 20 (actual)

## Conditions studied

- Postoperative Urinary Retention
- Sacrospinous Vaginal Vault Suspension
- Reconstructive Pelvic Surgery

## Interventions

- **DRUG:** Tizanidine

## Key facts

- **NCT ID:** NCT06258785
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-17
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-10-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258785, "Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06258785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*